Federica Linty

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.

Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 16, 2024

IgG1 glycosylation highlights premature aging in Down syndrome.

IgG1 glycosylation highlights premature aging in Down syndrome.

Journal: Aging cell
Published: December 14, 2023

Generation of human antibodies targeting human platelet antigen (HPA)-1a.

Generation of human antibodies targeting human platelet antigen (HPA)-1a.

Journal: Transfusion
Published: December 01, 2023

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.

Journal: iScience
Published: March 27, 2023

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees.

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees.

Journal: EBioMedicine
Published: August 05, 2022

Immunoassay for quantification of antigen-specific IgG fucosylation.

Immunoassay for quantification of antigen-specific IgG fucosylation.

Journal: EBioMedicine
Published: December 08, 2021

Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19.

Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19.

Journal: EBioMedicine
Published: November 17, 2021

Saliva SARS-CoV-2 Antibody Prevalence in Children.

Saliva SARS-CoV-2 Antibody Prevalence in Children.

Journal: Microbiology spectrum
Published: September 15, 2021

Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors.

Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors.

Journal: Clinical & translational immunology
Published: January 29, 2021

High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages.

High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages.

Journal: Science translational medicine
Published: November 25, 2020

Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.

Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.

Journal: European journal of immunology
Published: July 30, 2020

Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.

Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 06, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026